Hand Sanitizer Recalled Due to Manufacturing Practice Deviations
Fisher Scientific voluntarily recalls hand sanitizer due to manufacturing deviations. The recall affects products distributed after March 31, 2022.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Voluntary precautionary recall with no reported illnesses or injuries. Driven by regulatory non-compliance (expired temporary approval) and manufacturing practice deviations; classified FDA Class II but lacking reported harm indicators required for higher severity.
Plain-English summary
Fisher Scientific Co., LLC is voluntarily recalling HSANI4LI hand sanitizer, a 75% isopropyl alcohol solution packaged in 4-liter bottles. The recall affects 106 bottles distributed nationwide in the United States.
The recall is due to current Good Manufacturing Practice (CGMP) deviations. The FDA issued guidance requiring manufacturers to cease distributing hand sanitizer products produced under temporary pandemic emergency approval after March 31, 2022. All affected bottles were distributed after this regulatory deadline.
The recalled product includes lot numbers 202161, 202322, 202323, 202794, 202858, 203188, 203238, 203240, 203722, 203723, 203724, 203725, and 204852. Consumers and organizations that have received this product should discontinue use and contact Fisher Scientific for return instructions or proper disposal.
The recalled product
- Product
- Hand Sanitizer, HSANI4LI, (Isopropyl Alcohol), 75% Topical Solution, packaged in 4 L bottles, Thermo Fisher Scientific: Janssen Pharmaceuticalaan 3a, 2440 Geel - Belgium, 1 Reagent Lane, Fair Lawn, NJ 07410.
- Manufacturer
- Fisher Scientific Co., LLC
- Category
- Drug — Hand Sanitizer / Topical
- Hazard
- cgmp-violation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (12)
- Lot Numbers: 202161
- 202322
- 202323
- 202794
- 202858
- 203188
- 203238
- 203240
- 203722 203723
- 203724
- 203725
- 204852
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27